Charles Schwab Investment Management Inc Ionis Pharmaceuticals Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,481,440 shares of IONS stock, worth $45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,481,440
Previous 1,443,020
2.66%
Holding current value
$45 Million
Previous $57.8 Million
10.41%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
139MCall Options Held
957KPut Options Held
701K-
Vanguard Group Inc Valley Forge, PA16.5MShares$500 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$430 Million0.34% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$348 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$313 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$263 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.31B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...